Patents by Inventor Fredrik Kamme

Fredrik Kamme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100179310
    Abstract: Some aspects relate to methods for genetic analysis of selected cells from within a heterogeneous population of cells. The population of cells first can be partitioned. Selected cells are identified by imaging, and then specifically targeted and lysed by irradiation with an energy beam, resulting in specific release of their cellular contents into the culture medium. The culture medium then can be sampled and assayed for the desired nucleic acids.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 15, 2010
    Applicant: Cyntellect, Inc.
    Inventors: Fredrik Kamme, Gary Bright, Gustaf Angelborg, James Linton, Manfred Koller
  • Patent number: 7354742
    Abstract: The present invention provides a new method for producing amplified RNA from a selected set of cells. This method combines and utilizes known methods in a novel way to produce the gene expression profiles. The methods of the present invention utilize thermostable DNA polymerases and RNase H to produce high fidelity second strand synthesis of nucleic acids from selected cells in a highly efficient mariner and in substantially reduced time.
    Type: Grant
    Filed: February 22, 2002
    Date of Patent: April 8, 2008
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Fredrik Kamme, Jessica Y. Zhu
  • Publication number: 20060166258
    Abstract: To preserve RNA in a biological sample for analysis, the sample is incubated with an RNA preservative capable of precipitating RNA in an aqueous solution, such as a triphenylmethane dye (e.g., methyl green, crystal violet, pararosaniline, or tris-(4-aminophenyl)methane), cresyl violet, or cobalt ions. RNA preservation may be used in an immunostaining assay and other histochemical methods.
    Type: Application
    Filed: March 27, 2006
    Publication date: July 27, 2006
    Inventors: Fredrik Kamme, Bernhard Meurers, Dmitri Talantov, Jingxue Yu
  • Publication number: 20060105331
    Abstract: Methods are described for eliminating single-stranded oligonucleotides from a sample prior to RNA transcription, thereby reducing non-template derived production of RNA. In one embodiment, a sample containing the template for RNA transcription is treated with one or more exonucleases to remove single-stranded oligonucleotides from the reaction mixture prior to RNA transcription. In another embodiment, the sample containing the template for RNA transcription is contacted with an oligonucleotide complementary to the single-stranded oligonucleotide present in the sample, and allowed to hybridize to form double-stranded oligonucleotides.
    Type: Application
    Filed: May 30, 2003
    Publication date: May 18, 2006
    Inventors: Fredrik Kamme, Jessica Zhu
  • Publication number: 20030175714
    Abstract: The present invention provides a new method for producing amplified RNA from a selected set of cells. This method combines and utilizes known methods in a novel way to produce the gene expression profiles. The methods of the present invention utilize thermostable DNA polymerases and RNase H to produce high fidelity second strand synthesis of nucleic acids from selected cells in a highly efficient mariner and in substantially reduced time.
    Type: Application
    Filed: February 22, 2002
    Publication date: September 18, 2003
    Inventors: Fredrik Kamme, Jessica Y. Zhu
  • Publication number: 20020156038
    Abstract: Implementing gene expression to study drug action in the central nervous system is complicated by functional heterogeneity because of the existence of many different neuronal subtypes within the mammalian brain. The integration of laser capture microdissection (LCM) and RNA amplification with cDNA microarray technology allows for large-scale gene expression analysis at cellular level. Using this approach, we have generated gene expression profiles of imipramine, a reference antidepressant, and a new putative antidepressant, novelR1 in several laser-captured brain nuclei (locus coeruleus, dorsal raphe, hypothalamic paraventricular nucleus and hippocampus) of rats subjected to the chronic mild stress model (CMS) of depression.
    Type: Application
    Filed: October 4, 2001
    Publication date: October 24, 2002
    Inventors: Pascal Bonaventure, Hongqing Quo, Xuejun Liu, Fredrik Kamme, Bernhard Meurers, Josepha E.M.F. Leysen, Margot H.M. Bakker